个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Immunosuppression versus Supportive Care on Kidney Outcomes in IgA Nephropathy in the Real-World Setting

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Zhao Hao[1] * ; Li Yang[1] ; Sun Jingdi[1] ; Xu Gang[2] ; Wang Cheng[3] ; Zhou Shiyu[1] ; Nie Sheng[1] ; Li Yanqin[1] ; Su Licong[1] ; Chen Ruixuan[1] ; Cao Yue[1] ; Gao Qi[1] ; Hu Ying[4] ; Li Hua[5] ; Yang Qiongqiong[6] ; Wan Qijun[7] ; Liu Bicheng[8] ; Xu Hong[9] ; Li Guisen[10] ; Weng Jianping[11] ; Chen Chunbo[12] ; Liu Huafeng[13] ; Shi Yongjun[14] ; Zha Yan[15] ; Kong Yaozhong[16] ; Su Guobin[17] ; Tang Ying[18] ; Zhou Yilun[19] ; Guo Aixin[20] ; Gong Mengchun[20] ; Xu Xin[1,*2] ; Hou Fan Fan[1,*1] ;
机构： [1]National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology,Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China [2]Division of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [3]Division of Nephrology, Department of Medicine, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai, China [4]The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China [5]Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China [6]Department of Nephrology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China [7]The Second People’s Hospital of Shenzhen, Shenzhen University, Shenzhen, China [8]Institute of Nephrology, Zhongda Hospital, Southeast University School of Medicine, Nanjing, China [9]Children's Hospital of Fudan University, Shanghai, China [10]Renal Department and Institute of Nephrology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Sichuan Clinical Research Center for Kidney Diseases, Chengdu, China [11]Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China [12]Department of Critical Care Medicine, Maoming People's Hospital, Maoming, China [13]Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, China [14]Huizhou Municipal Central Hospital, Sun Yat-Sen University, Huizhou, China [15]Guizhou Provincial People’s Hospital, Guizhou University, Guiyang, China [16]Department of Nephrology, the First People's Hospital of Foshan, Foshan, Guangdong, China [17]Department of Nephrology, Guangdong Provincial Hospital of Chinese Medicine, The Second Affiliated Hospital, The Second Clinical College, Guangzhou University of Chinese Medicine, Guangzhou, China [18]The Third Affiliated Hospital of Southern Medical University, Guangzhou, China [19]Department of Nephrology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China [20]DHC Technologies, Beijing, China
出处：
DOI： 10.2215/CJN.0000000000000215
ISSN：

摘要：
Background The efficacy of immunosuppression in management of IgA nephropathy remains highly controversial. The study was conducted to assess the effect of immunosuppression, compared with supportive care, in real-world setting of IgA nephropathy. Methods A cohort of 3946 patients with IgA nephropathy, including 1973 new-users of immunosuppressive agents and 1973 propensity score- matched recipients of supportive care, in a nationwide register data from Jan 2019 to May 2022 in China was analyzed. The primary outcome was a composite of 40% eGFR decrease of the baseline, kidney failure, and all-cause mortality. A Cox proportional hazards model was used to estimate the effects of immunosuppression on the composite outcomes and its components in the propensity score matched cohort. Results Among 3946 individuals (mean [SD] age 36 [10] years, mean [SD] eGFR 85 [28] mL/min/1.73m2, and mean [SD] proteinuria 1.4 [1.7] g/24h), 396 primary composite outcomes events were observed, of which 156 (8%) were in the immunosuppression group and 240 (12%) in the supportive care group. Compared with supportive care, immunosuppression treatment reduced the risk of the primary outcome events by 40% (adjusted hazard ratio 0.60; 95% CI, 0.48-0.75). Comparable effect size was observed for glucocorticoid monotherapy and mycophenolate mofetil alone. In the pre-specified subgroup analysis, the treatment effects of immunosuppression were consistent across ages, genders, levels of proteinuria, and the values of eGFR at baseline. Serious adverse events were more frequent in the immunosuppression group compared with the supportive care group. Conclusions Immunosuppressive therapy, compared with supportive care, was associated with a 40% lower risk of clinically important kidney outcomes in patients with IgA nephropathy.Copyright © 2023 by the American Society of Nephrology.

语种：
外文
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 1 区 医学
小类 | 1 区 泌尿学与肾脏学
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 泌尿学与肾脏学
JCR分区：
出版当年[2021]版：
Q1 UROLOGY & NEPHROLOGY
最新[2023]版：
Q1 UROLOGY & NEPHROLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者：
第一作者机构： [1]National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology,Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China
通讯作者：
通讯机构： [1]National Clinical Research Center for Kidney Disease, State Key Laboratory of Organ Failure Research, Guangdong Provincial Institute of Nephrology,Guangdong Provincial Key Laboratory of Renal Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China [*1]Renal Division, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Ave, Guangzhou 510515, China. [*2]National Clinical Research Center for Kidney Disease, 1838 North Guangzhou Ave, Guangzhou 510515, China.
推荐引用方式(GB/T 7714)：
Zhao Hao,Li Yang,Sun Jingdi,et al.Immunosuppression versus Supportive Care on Kidney Outcomes in IgA Nephropathy in the Real-World Setting[J].CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY.2023,18(9):1186-1194.doi:10.2215/CJN.0000000000000215.
APA：
Zhao Hao,Li Yang,Sun Jingdi,Xu Gang,Wang Cheng...&Hou Fan Fan.(2023).Immunosuppression versus Supportive Care on Kidney Outcomes in IgA Nephropathy in the Real-World Setting.CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY,18,(9)
MLA：
Zhao Hao,et al."Immunosuppression versus Supportive Care on Kidney Outcomes in IgA Nephropathy in the Real-World Setting".CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 18..9(2023):1186-1194

资源点击量：2018 今日访问量：0 总访问量：645 更新日期：2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持：重庆聚合科技有限公司 地址：广州市越秀区大德路111号